Allgens Medical Technology CO., LTD. (688613.SS)
CNY 18.52
(0.76%)
CNY 18.52
(0.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 226.47 Million | 245.3 Million | 236.06 Million | 183.76 Million | 168.59 Million | 123.68 Million |
| Cost of Revenue | 39.23 Million | 40.77 Million | 34.57 Million | 29.75 Million | 28.85 Million | 20.8 Million |
| Gross Profit | 187.23 Million | 204.52 Million | 201.48 Million | 154 Million | 139.73 Million | 102.88 Million |
| Operating Expenses | 138.24 Million | 121.26 Million | 80.74 Million | 54.61 Million | 77.59 Million | 69.12 Million |
| Selling, General and Administrative Expenses | 88.18 Million | 40.05 Million | 27.25 Million | 15.88 Million | 29.86 Million | 39.7 Million |
| Research and Development Expenses | 45.5 Million | 57.46 Million | 33.23 Million | 16 Million | 22.49 Million | 18.01 Million |
| Other Expenses | - | 23.75 Million | 20.26 Million | 22.71 Million | 25.23 Million | -549.35 Thousand |
| Cost and Expenses | 177.48 Million | 162.04 Million | 115.32 Million | 84.37 Million | 106.45 Million | 89.92 Million |
| Operating Income | 48.99 Million | 96.31 Million | 134.91 Million | 102.18 Million | 74.44 Million | 34.79 Million |
| Interest Expense | 3.14 Million | 1.86 Million | 3.41 Million | 1.27 Million | 1.02 Million | - |
| Income Tax Expense | -3.87 Million | 4.5 Million | 13.97 Million | 14.96 Million | 10.35 Million | 6.74 Million |
| Earnings before Tax | 49.09 Million | 96.2 Million | 132.04 Million | 102.07 Million | 74.55 Million | 34.25 Million |
| Net Income | 54.23 Million | 95.21 Million | 120.78 Million | 88.94 Million | 67.78 Million | 32.98 Million |
| Earnings Per Share Basic | 0.41 | 0.71 | 0.91 | 0.67 | 0.51 | 0.34 |
| Earnings Per Share Diluted | 0.41 | 0.71 | 0.91 | 0.67 | 0.51 | 0.34 |
| Weighted Average Shares Outstanding | 132.27 Million | 133.33 Million | 133.33 Million | 133.33 Million | 133.33 Million | 97.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 132.27 Million | 133.33 Million | 133.33 Million | 133.33 Million | 133.33 Million | 97.01 Million |
| Gross Margin | 0.83 | 0.83 | 0.85 | 0.84 | 0.83 | 0.83 |
| EBIT Margin | 0.31 | 0.44 | 0.58 | 0.61 | 0.44 | 0.33 |
| Profit Margin | 0.24 | 0.39 | 0.51 | 0.48 | 0.40 | 0.27 |
| EBITDA | 69.28 Million | 118.37 Million | 148.63 Million | 111.91 Million | 87.46 Million | 42.28 Million |
| Earnings Before Tax Margin | 0.22 | 0.39 | 0.57 | 0.56 | 0.44 | 0.28 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 47.3 Million | 51.89 Million | 46.5 Million | 42.87 Million | 226.47 Million | 65.59 Million |
| Cost of Revenue | 14.56 Million | 19.01 Million | 9.29 Million | 8.26 Million | 39.23 Million | 10.23 Million |
| Gross Profit | 32.74 Million | 32.87 Million | 37.2 Million | 34.61 Million | 187.23 Million | 55.36 Million |
| Operating Expenses | 36.9 Million | 40.61 Million | 35.2 Million | 48.15 Million | 177.43 Million | 42.4 Million |
| Selling, General and Administrative Expenses | 29.26 Million | 32.9 Million | 27.64 Million | 7.19 Million | - | 45.04 Million |
| Research and Development Expenses | 7.63 Million | 7.7 Million | 7.55 Million | 15.1 Million | - | 12.7 Million |
| Other Expenses | - | -64.07 | -164.84 Thousand | -48.15 Million | -177.43 Million | -82.56 Thousand |
| Cost and Expenses | 51.46 Million | 59.62 Million | 44.49 Million | 48.15 Million | 177.43 Million | 52.63 Million |
| Operating Income | -4.15 Million | -7.73 Million | 2 Million | -5.27 Million | 49.03 Million | 18.14 Million |
| Interest Expense | 713.98 Thousand | - | 476.95 Thousand | 1.56 Million | 3.12 Million | 445.14 Thousand |
| Income Tax Expense | 7.07 Million | -83.97 Thousand | 256.29 Thousand | -6.3 Million | -3.87 Million | -535.61 Thousand |
| Earnings before Tax | 1.31 Million | -530.21 Thousand | 5.64 Million | -5.09 Million | 49.13 Million | 18.05 Million |
| Net Income | -4.33 Million | 2.28 Million | 6.93 Million | 2.1 Million | 54.23 Million | 18.59 Million |
| Earnings Per Share Basic | -0.03 | 0.02 | 0.05 | 0.01 | - | 0.14 |
| Earnings Per Share Diluted | -0.03 | 0.02 | 0.05 | 0.01 | - | 0.14 |
| Weighted Average Shares Outstanding | 135.55 Million | 135.55 Million | 133.33 Million | 143.84 Million | 132.27 Million | 133.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 135.55 Million | 135.55 Million | 133.33 Million | 143.83 Million | 132.27 Million | 133.33 Million |
| Gross Margin | 0.69 | 0.63 | 0.80 | 0.81 | 0.83 | 0.84 |
| EBIT Margin | 0.04 | -0.04 | -0.05 | -0.11 | - | 0.22 |
| Profit Margin | -0.09 | 0.04 | 0.15 | 0.05 | 0.24 | 0.28 |
| EBITDA | 2.03 Million | -1.96 Million | -2.11 Million | -4.68 Million | - | 14.12 Million |
| Earnings Before Tax Margin | -0.09 | -0.15 | 0.04 | -0.12 | 0.22 | 0.28 |
IMCO
IBIO
MONOF
002656
VRE
ECORF